Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE American:OGEN)

0.39
Delayed Data
As of Oct 23
 +0.03 / +8.33%
Today’s Change
0.28
Today|||52-Week Range
1.10
-27.78%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.36
Today’s open0.38
Day’s range0.37 - 0.39
Volume21,209
Average volume (3 months)65,992
Market cap$17.7M
Dividend yield--
Data as of 3:51pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+40.69%
Earnings growth (this year)-21.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.90

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc+0.10+8.00%
CBIOCatalyst Biosciences...-0.13-2.58%
NVGNNovogen Ltd+0.08+2.58%
ANTHAnthera Pharmaceutic...-0.09-5.42%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts